title: Reply to Comment on: Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
authors.affiliation: Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Dodgshun
authors.affiliation: Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia.
authors.forename: Jordan R
authors.initials: JR
authors.lastname: Hansford
authors.affiliation: Department of Allergy and Immunology, Royal Children's Hospital, Victoria, Australia.
authors.forename: Theresa
authors.initials: T
authors.lastname: Cole
authors.affiliation: Department of Allergy and Immunology, Royal Children's Hospital, Victoria, Australia.
authors.forename: Sharon
authors.initials: S
authors.lastname: Choo
authors.affiliation: Children's Cancer Centre, Royal Children's Hospital, Victoria, Australia.|Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Sullivan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D016190:Carboplatin / Q000009:adverse effects*; D016543:Central Nervous System Neoplasms / Q000628:therapy*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000628:therapy*; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin